(Q35838505)

10 August 2017

1 reference

title

Protection against stroke and dementia: an update on the latest clinical trial evidence (English)

1 reference

10 August 2017

1 reference

Bryan Williams

1

1 reference

10 August 2017

publication date

1 August 2004

1 reference

Current Hypertension Reports

10 August 2017

published in

1 reference

10 August 2017

volume

6

1 reference

10 August 2017

issue

4

1 reference

10 August 2017

page(s)

307-313

1 reference

Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men.

10 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11906-004-0026-4

Mild cognitive impairment in the elderly: predictors of dementia

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11906-004-0026-4

Cognitive performance in hypertensive and normotensive older subjects

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11906-004-0026-4

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

21 January 2018

1 reference

12 December 2020

Principal Results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) Trial

1 reference

12 December 2020

Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003.

1 reference

12 December 2020

15-year longitudinal study of blood pressure and dementia

1 reference

12 December 2020

The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial

1 reference

12 December 2020

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

12 December 2020

Use of ramipril in preventing stroke: double blind randomised trial

1 reference

12 December 2020

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

12 December 2020

A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial

1 reference

12 December 2020

Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions

1 reference

12 December 2020

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

1 reference

12 December 2020

A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

1 reference

12 December 2020

The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial of cardiovascular events in hypertension. Rationale and design.

1 reference

12 December 2020

Incidence of dementia after ischemic stroke: results of a longitudinal study

1 reference

12 December 2020

The renin angiotensin system and cardiovascular disease: hope or hype?

1 reference

12 December 2020

The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors

1 reference

12 December 2020

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1 reference

12 December 2020

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

1 reference

12 December 2020

Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services

1 reference

12 December 2020

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials

1 reference

12 December 2020

Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial

1 reference

12 December 2020

Blood pressure and stroke: an overview of published reviews

1 reference

12 December 2020

Blood pressure and cardiovascular disease in the Asia Pacific region

1 reference

12 December 2020

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

1 reference

12 December 2020

Blood pressure and cognitive performance. The Framingham Study

1 reference

12 December 2020

Longitudinally measured blood pressure, antihypertensive medication use, and cognitive performance: the Framingham Study

1 reference

12 December 2020

The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study

1 reference

12 December 2020

The prevalence of dementia: a quantitative integration of the literature

1 reference

12 December 2020

Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study

1 reference

12 December 2020

Comparative effects of ramipril on ambulatory and office blood pressures: a HOPE Substudy.

1 reference

12 December 2020

10.1007/S11906-004-0026-4

Identifiers

DOI

1 reference

10 August 2017

1 reference